Records 1 - 5 (of 5 Records) |
Query Trace: Opioid[original query]>>Guidelines Related[Product Type] |
---|
Dutch Pharmacogenetics Working Group (DPWG) guideline for the gene–drug interaction between CYP2D6 and opioids (codeine, tramadol and oxycodone) M Matic et al, The Pharmacogenomics Journal, July 15, 2021 |
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for CYP2D6, OPRM1, and COMT genotype and select opioid therapy. Crews Kristine R et al. Clinical pharmacology and therapeutics 2021 Jan |
Local Coverage Determination (LCD): CYP2C19, CYP2D6, CYP2C9, and VKORC1 Genetic Testing (L35698) The U.S. Centers for Medicare & Medicaid Services |
Local Coverage Determination (LCD): Biomarkers Overview (L35062) The U.S. Centers for Medicare & Medicaid Services |
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update. |